These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8042874)

  • 21. Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients.
    Wang PH; Yuan CC; Chao HT; Juang CM; Ng HT
    Eur J Gynaecol Oncol; 1998; 19(6):571-4. PubMed ID: 10215444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
    Rosen AC; Klein M; Hafner E; Lahousen M; Graf AH; Reiner A
    Gynecol Obstet Invest; 1999; 47(1):45-51. PubMed ID: 10026026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery and radiotherapy in the treatment of primary carcinoma of the Fallopian tube--report of 18 cases.
    Wong WS; Tindall VR; Wagstaff J; Bramwell V; Crowther D
    Aust N Z J Obstet Gynaecol; 1985 Aug; 25(3):211-5. PubMed ID: 3866560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
    Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
    Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy.
    Prasad U; Wahid MI; Jalaludin MA; Abdullah BJ; Paramsothy M; Abdul-Kareem S
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):648-55. PubMed ID: 12062608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of radiotherapy in the management of primary carcinoma of the fallopian tube.
    Singhal S; Sharma S; De S; Fernandes P; Chander S; Rath GK
    Indian J Med Sci; 1991 Mar; 45(3):58-60. PubMed ID: 1916973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamide.
    Jacobs AJ; McMurray EH; Parham J; Kao MS; Galakatos AE; Perez CA; Camel HM
    Am J Clin Oncol; 1986 Oct; 9(5):436-9. PubMed ID: 3776907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary fallopian tube carcinoma: a retrospective clinicopathologic study.
    Singhal P; Odunsi K; Rodabaugh K; Driscoll D; Lele S
    Eur J Gynaecol Oncol; 2006; 27(1):16-8. PubMed ID: 16550961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
    Pectasides D; Pectasides E; Papaxoinis G; Andreadis C; Papatsibas G; Fountzilas G; Pliarchopoulou K; Macheras A; Aravantinos G; Economopoulos T
    Gynecol Oncol; 2009 Oct; 115(1):97-101. PubMed ID: 19615725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma.
    Smith MR; Peters WA; Drescher CW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1677-81; discussion 1681-2. PubMed ID: 8203425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fallopian tube carcinoma.
    Nikrui N; Duska LR
    Surg Oncol Clin N Am; 1998 Apr; 7(2):363-73. PubMed ID: 9537982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
    Bamias A; Bamia C; Zagouri F; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
    Oncology; 2013; 84(3):158-65. PubMed ID: 23296063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
    Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.